This is the authors' abstract. We don't add key points for this paper.
In the absence of effective pharmaceutical interventions early in an infectious disease outbreak, non-pharmaceutical measures, especially isolating infected individuals, critically limit its impact. The ongoing COVID-19 pandemic has sparked debates on optimal isolation guidelines. This study proposes a variable isolation period approach (variable-period approach), tailoring isolation durations for distinct population groups with varied viral load dynamics. To compare our variable-period approach with a fixed-period strategy, we developed a simulation model generating synthetic longitudinal SARS-CoV-2 viral load data. The data was generated from the viral dynamics model parameterized using SARS-CoV-2 Delta patient data in Singapore, accounting for age and vaccination status. Findings show that age and vaccination status significantly influence viral dynamics, with younger age and vaccination linked to shorter viral shedding durations. The variable-period framework suggests longer isolation lengths for older and unvaccinated individuals. By setting the leaking risk (risk of remaining infectious at the end of isolation) below 10%, the optimal fixed-period isolation is 14 days, with an average excess isolation burden of 7.4 unnecessary days. In contrast, the variable-period guideline reduces the excess isolation burden to 6.0 days, with the optimal isolation periods ranging from 9 to 16 days, depending on the population group. We confirmed similar results when we used the effective reproduction number as an alternative to the leaking risk. In this case, study using the SARS-CoV-2 Delta variant, our analysis demonstrates that unnecessary time spent in isolation can be reduced by adopting variable-period guidelines based on patient characteristics. The isolation of infected patients is crucial in minimizing the impact of a pandemic. Nevertheless, it can significantly burden the patients themselves. Therefore, guidelines for isolation should be established to decrease unnecessary isolation periods, without relying solely on viral tests. Here, we introduce a protocol to evaluate guidelines with fixed and variable isolation periods. Our analysis revealed that adjusting isolation lengths based on age and vaccination status, rather than enforcing a uniform period for all patients, can reduce the necessary isolation period by 1.4 to 1.8 days per person on average. Customizing the isolation period according to patient characteristics is justified to decrease the duration of redundant isolation, concurrently mitigating the risk of further transmission. Ejima et al. introduce a computational protocol to evaluate isolation guidelines, showing that adjusting isolation durations based on age and vaccination status reduces unnecessary isolation by 1.4 to 1.8 days per person while maintaining safety. Tailored isolation periods minimize redundant isolation and mitigate transmission risks.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ejima et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: